Encision enters into purchasing agreement with HealthTrust

NewsGuard 100/100 Score
Editorial Checklist Reviewed
Jun 2 2010Encision Inc.

Encision Inc. (OTC Bulletin Board: ECIA), a medical device company owning patented surgical technology that is emerging as a standard of care in minimally-invasive surgery, announced today that it has entered into a purchasing agreement with HealthTrust Purchasing Group, LP ("HealthTrust"), effective June 1, 2010.  The products designated in the agreement are "Laparoscopic Safety Instruments – Active Electrode Monitoring Laparoscopy".

"We are pleased to have contractual access to HealthTrust member facilities.  These facilities enjoy a reputation for their high contract compliance," said Jack Serino, President and CEO of Encision Inc.

Source:

Encision Inc.

Posted in:

Tags: , , , ,

Comments (0)

Suggested Reading

Advances and hurdles: The impact of AI on oncology care efficiency and mortality rates
Novel SARS-CoV-2 mutations found in floodwaters near homeless communities
New machine learning model achieves breakthrough in heart disease prediction with over 95% accuracy
Mapping the Microbiome: Dr. Abidemi Junaid on the Groundbreaking Vagina Chip
From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech
Personality dictates binge-watching: Study reveals why we can't stop streaming
New vaccine promises broad protection against SARS-CoV-2 and other sarbecoviruses
Emerging trends in wearable breath sensors aim at personalized healthcare solutions

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
(Logout)
Post

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback

You might also like...
Revolutionizing diabetes management with reliable blood glucose monitoring without finger pricking